Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Yule

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 15, 2019
A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorderGagan Joshi, Maura DiSalvo, Janet Wozniak, et al.
Journal of Clinical Psychopharmacology|December 20, 2018
Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical TrialCraig Surman, Atilla Ceranoglu, Carrie Vaudreuil, et al.
The Journal of Clinical Psychiatry|August 31, 2016
Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct DisorderTimothy E Wilens, Joseph Biederman, MaryKate Martelon, et al.
European Addiction Research|July 8, 2020
International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use DisorderHeval Özgen, Renske Spijkerman, Moritz Noack, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|August 16, 2021
[International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]Heval Özgen, Renske Spijkerman, Moritz Noack, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|October 15, 2019
A prospective open-label trial of long-acting liquid methylphenidate for the treatment of attention deficit/hyperactivity disorder in intellectually capable adults with autism spectrum disorderGagan Joshi, Maura DiSalvo, Janet Wozniak, et al.
Journal of Clinical Psychopharmacology|December 20, 2018
Does L-Methylfolate Supplement Methylphenidate Pharmacotherapy in Attention-Deficit/Hyperactivity Disorder?: Evidence of Lack of Benefit From a Double-Blind, Placebo-Controlled, Randomized Clinical TrialCraig Surman, Atilla Ceranoglu, Carrie Vaudreuil, et al.
The Journal of Clinical Psychiatry|August 31, 2016
Further Evidence for Smoking and Substance Use Disorders in Youth With Bipolar Disorder and Comorbid Conduct DisorderTimothy E Wilens, Joseph Biederman, MaryKate Martelon, et al.
European Addiction Research|July 8, 2020
International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use DisorderHeval Özgen, Renske Spijkerman, Moritz Noack, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|August 16, 2021
[International Consensus Statement for the Screening, Diagnosis, and Treatment of Adolescents with Concurrent Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder]Heval Özgen, Renske Spijkerman, Moritz Noack, et al.
Pageof 2